HEP-1

• Target :

  Influenza Virus|||HIV Protease|||HCV Protease|||Interleukin|||Virus Protease

• Related Pathways :

  Proteases/Proteasome|||Immunology/Inflammation|||Microbiology/Virology

• Bioactivity :

  HEP-1 (Human ezrin peptide (324-337) ) is an orally active peptide with anti-HIV properties, shown to enhance antibody titers after hepatitis B vaccination. Its potential in viral infection treatment warrants further investigation [1].

• Smiles :

  [C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@H]([C@@H](C)O)N)=O)CCC(O)=O)=O)CCCCN)=O)CCCCN)=O)CCCNC(=N)N)=O)(C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](CCC(O)=O)C(O)=O)=O)CCCCN)=O)CCC(O)=O)=O)CCCNC(=N)N)=O)CCC(O)=O)=O)C(C)C)=O)[C@@H](C)O)=O)CCC(O)=O)=O)CCCNC(=N)N

• Molecular Formula :

  C74H132N26O27

• Molecular Weight :

  1818

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  174641-44-2